Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001387714 | SCV001588404 | pathogenic | Gorlin syndrome; Medulloblastoma | 2020-02-26 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. Loss-of-function variants in SUFU are known to be pathogenic (PMID: 22508808, 25403219). This variant has been observed in individual(s) with basal cell nevus syndrome (Invitae). This variant is an out-of-frame deletion of the genomic region encompassing exon(s) 4-6 of the SUFU gene. This is expected to create a premature translational stop signal and result in an absent or disrupted protein product. |